bpc-157 for gut inflammation 🧬 Peptide Therapy Stable Gastric Pentadecapeptide BPC 157,

Share your full health history in the intake

Most commonly via subcutaneous injection (under the skin), which provides the most reliable delivery

MIC (Methionine, Inositol, Choline) helps with fat metabolism, assisting in weight loss and fat breakdown

This varies for everyone, but most people see the best result after 4 to 6 treatments, spaced 2-4 weeks apart

Common side effects reported with retatrutide include: Nausea, vomiting, and diarrhoea (most frequent, particularly during dose escalation) Decreased appetite Constipation Injection site reactions Mild increases in heart rate Cagrilintide has demonstrated a generally well-tolerated profile, with gastrointestinal symptoms also being the most commonly reported adverse effects